Personal profile
Biography
Dr. Sargazi is a dedicated researcher with a PhD in Clinical Biochemistry and advanced training in cellular and molecular biology, complemented by a fellowship in immunoassays. He has made significant contributions to nanobiochemistry and molecular diagnostics. With an H-index of 40 and extensive publication record exceeding 160 peer-reviewed articles receiving >8000 citations, his work exemplifies a commitment to advancing biomedical research and translating scientific innovations into practical applications. Recognized among the top 2% of scientists worldwide by the Elsevier/Stanford Lists (2023, 2024, and 2025), and awarded several prestigious honors, Dr. Sargazi combines a passion for impactful research, teaching, and collaboration, while inspiring the next generation of scientists.
Education/Academic qualification
Clinical Biochemistry, PhD, Synthetic lethality through combined DNA repair–targeting therapies
8 Feb 2015 → 21 Nov 2018
Award Date: 21 Nov 2018
Research expertise keywords
- Molecular biology
- Nanobiochemistry
- Pharmacology and Toxicology
- Aging Biology
- Cancer Biology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Delivery of GRg3 via alginate/PLGA nanoparticles: physicochemical, cellular, and in vivo biocompatibility assessments
Sargazi, S., Mirinejad, S., Hajinezhad, M. R., Madani, F., Majidpour, M. & Barani, M., Jan 2026, In: Drug Development and Industrial Pharmacy. 52, 1, p. 73-89 17 p.Research output: Contribution to journal › Article › peer-review
-
g-C₃N₅/AuNPs-based electrochemical aptasensor for ultrasensitive doxorubicin detection in human plasma and urine
Poormolaie, N., Bohlooli, M., Movahedi, M. & Sargazi, S., Jan 2026, In: Microchemical Journal. 220, 12 p., 116282.Research output: Contribution to journal › Article › peer-review
-
Ginsenoside Rg3-encapsulated pegylated niosomes exhibit multimodal therapeutic potential in Alzheimer's disease
Barani, M., Zargari, F., Mirinejad, S., Madani, F., Hajinezhad, M. R. & Sargazi, S., 20 Jan 2026, In: Scientific Reports. 16, 1, 23 p., 2547.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Decoding the Link: Exploring FMO3 Gene Variations as a Key to Understanding Type Two Diabetes Through Bioinformatics and Case–Control Analyses
Shokati, S., Sargazi, S., Majidpour, M., Mirinejad, S., Naderi Ghale-Noie, Z., Shahraki, M., Sargazi, S. & Piri, M., 2025, In: Indian Journal of Clinical Biochemistry. 15 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Engineering pH-responsive niosomes with ergosterol and CHEMS for controlled carfilzomib release: insights from in vitro and in vivo studies
Hajinezhad, M. R., Fathi-karkan, S., Roostaee, M., Sargazi, S., Mirinejad, S., Sheervalilou, R., Sargazi, S. & Barani, M., Sept 2025, In: Drug Development and Industrial Pharmacy. 51, 9, p. 1122-1137 16 p.Research output: Contribution to journal › Article › peer-review
4 Link opens in a new tab Citations (Scopus)